Northwestern Mutual Wealth Management’s Oncolytics Biotech ONCY Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.43K	Buy	+6,393	New	+$6.36K	﹤0.01%	3282

Other funds holding ONCY

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SFP

Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Northwestern Mutual Wealth Management's ONCY Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Oncolytics Biotech (ONCY) in Q1 2026: 6,393 shares worth $5.43K. The stake represents ﹤0.01% of the portfolio and ranks #3282 among its holdings.

59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

Northwestern Mutual Wealth Management held 6,393 shares of Oncolytics Biotech worth $5.43K as of Q1 2026.
Oncolytics Biotech was a new Northwestern Mutual Wealth Management position in Q1 2026.
Oncolytics Biotech made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3282 holding.
59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.